Shibuya M - Search Results

1

Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Adachi H, Nakae K, Sakamoto S, Nosaka C, Atsumi S, Shibuya M, Higashi N, Nakajima M, Irimura T, Nishimura Y. Adachi H, et al. Among authors: shibuya m. J Antibiot (Tokyo). 2017 Nov 1. doi: 10.1038/ja.2017.138. Online ahead of print. J Antibiot (Tokyo). 2017. PMID: 29089599 Review.

2

Vegfrecine, an inhibitor of VEGF receptor tyrosine kinases isolated from the culture broth of Streptomyces sp.

Nosaka C, Adachi H, Sawa R, Nakae K, Atsumi S, Kinoshita N, Kubota Y, Igarashi M, Sei Y, Yamaguchi K, Shibuya M, Nishimura Y, Akamatsu Y. Nosaka C, et al. Among authors: shibuya m. J Nat Prod. 2013 Apr 26;76(4):715-9. doi: 10.1021/np300535c. Epub 2013 Feb 15. J Nat Prod. 2013. PMID: 23414235

3

New anti-cancer chemicals Ertredin and its derivatives, regulate oxidative phosphorylation and glycolysis and suppress sphere formation in vitro and tumor growth in EGFRvIII-transformed cells.

Atsumi S, Nosaka C, Adachi H, Kimura T, Kobayashi Y, Takada H, Watanabe T, Ohba S, Inoue H, Kawada M, Shibasaki M, Shibuya M. Atsumi S, et al. Among authors: shibuya m. BMC Cancer. 2016 Jul 19;16:496. doi: 10.1186/s12885-016-2521-9. BMC Cancer. 2016. PMID: 27431653 Free PMC article.

4

Corrigendum: Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Adachi H, Nakae K, Sakamoto S, Nosaka C, Atsumi S, Shibuya M, Higashi N, Nakajima M, Irimura T, Nishimura Y. Adachi H, et al. Among authors: shibuya m. J Antibiot (Tokyo). 2018 Feb;71(2):349. doi: 10.1038/ja.2017.149. J Antibiot (Tokyo). 2018. PMID: 29375138

5

Structure-activity relationships of natural quinone vegfrecine analogs with potent activity against VEGFR-1 and -2 tyrosine kinases.

Adachi H, Nosaka C, Atsumi S, Nakae K, Umezawa Y, Sawa R, Kubota Y, Nakane C, Shibuya M, Nishimura Y. Adachi H, et al. Among authors: shibuya m. J Antibiot (Tokyo). 2021 Oct;74(10):734-742. doi: 10.1038/s41429-021-00445-y. Epub 2021 Jul 20. J Antibiot (Tokyo). 2021. PMID: 34282315

6

VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases.

Shibuya M. Shibuya M. Endocr Metab Immune Disord Drug Targets. 2015;15(2):135-44. doi: 10.2174/1871530315666150316121956. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 25772179 Review.

7

Tyrosine Kinase Receptor Flt/VEGFR Family: Its Characterization Related to Angiogenesis and Cancer.

Shibuya M. Shibuya M. Genes Cancer. 2010 Nov;1(11):1119-23. doi: 10.1177/1947601910392987. Genes Cancer. 2010. PMID: 21779435 Free PMC article.

8

[Tumor angiogenesis and its inhibitors].

Shibuya M. Shibuya M. Nihon Rinsho. 2012 Nov;70 Suppl 8:149-53. Nihon Rinsho. 2012. PMID: 23513829 Japanese. No abstract available.

9

Hypoxia-inducible factor-1β is essential for upregulation of the hypoxia-induced FLT1 gene in placental trophoblasts.

Sasagawa T, Nagamatsu T, Yanagisawa M, Fujii T, Shibuya M. Sasagawa T, et al. Among authors: shibuya m. Mol Hum Reprod. 2021 Nov 27;27(12):gaab065. doi: 10.1093/molehr/gaab065. Mol Hum Reprod. 2021. PMID: 34665260 Free PMC article.

10

VEGFR and type-V RTK activation and signaling.

Shibuya M. Shibuya M. Cold Spring Harb Perspect Biol. 2013 Oct 1;5(10):a009092. doi: 10.1101/cshperspect.a009092. Cold Spring Harb Perspect Biol. 2013. PMID: 24086040 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,307 results

Search Page

Filters